Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Protein Complexes with Interchangeable Parts01:57

Protein Complexes with Interchangeable Parts

2.9K
Groups of proteins may form a complex where each protein in this complex has a different role in the overall execution of the complex’s function. Often some of the proteins in the complex can be replaced by a closely related variant to give a complex that contains many of the same components yet is functionally distinct.
The SCF ubiquitin ligase is a protein complex of five individual proteins. This complex attaches ubiquitin to other target proteins to mark them for degradation. In order...
2.9K
Protein Complex Assembly02:41

Protein Complex Assembly

16.8K
Proteins can form homomeric complexes with another unit of the same protein or heteromeric complexes with different types.  Most protein complexes self-assemble spontaneously via ordered pathways, while some proteins need assembly factors that guide their proper assembly. Despite the crowded intracellular environment, proteins usually interact with their correct partners and form functional complexes.
Many viruses self-assemble into a fully functional unit using the infected host cell to...
16.8K
Complex Numbers01:29

Complex Numbers

322
The real number system cannot represent the square root of a negative number, which restricts solutions for certain equations, such as quadratics with negative discriminants. To address this, the complex number system was developed, introducing the imaginary unit i, where i = √(-1). This extension allows for the representation of all roots, including those involving negative radicands.A complex number is written in the form x + yi, where x and y are real numbers. Here, x represents the...
322
Formation of Complex Ions03:45

Formation of Complex Ions

26.2K
A type of Lewis acid-base chemistry involves the formation of a complex ion (or a coordination complex) comprising a central atom, typically a transition metal cation, surrounded by ions or molecules called ligands. These ligands can be neutral molecules like H2O or NH3, or ions such as CN− or OH−. Often, the ligands act as Lewis bases, donating a pair of electrons to the central atom. These types of Lewis acid-base reactions are examples of a broad subdiscipline called coordination...
26.2K
Tonsillitis II: Management01:26

Tonsillitis II: Management

443
This lesson will focus on the different treatment options for managing tonsillitis, which typically depend on the cause and severity.
443
Impression Management Techniques I: Managing Appearances01:29

Impression Management Techniques I: Managing Appearances

220
Appearance is a multidimensional aspect of self-presentation that encompasses observable attributes such as clothing, grooming, speech, and nonverbal behavior. These elements are often strategically managed to align with socially constructed expectations in different settings. For instance, individuals tailor their appearance during job interviews, social gatherings, or athletic events to meet the perceived norms of those environments.Contextual Adaptation and Social SignalsThe research...
220

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Popping FVIII concentrates into an updated classification.

Blood advances·2026
Same author

Integration of Efanesoctocog Alfa in Clinical Practice for Children, Adolescents, and Young Adults With Severe Haemophilia A.

Haemophilia : the official journal of the World Federation of Hemophilia·2025
Same author

Safety and Effectiveness of Emicizumab in People With Haemophilia A Enrolled in the ATHN 7 Haemophilia Natural History Study.

Haemophilia : the official journal of the World Federation of Hemophilia·2025
Same author

Emicizumab for preventing intracranial hemorrhage in infants with severe hemophilia A: a cost-effectiveness analysis.

Blood advances·2025
Same author

A literature review of major surgery experience with emicizumab in people with hemophilia A without factor VIII inhibitors.

Research and practice in thrombosis and haemostasis·2025
Same author

2025 Clinical Trials Update on Hemophilia, VWD, and Rare Inherited Bleeding Disorders.

American journal of hematology·2025
Same journal

Barriers, Breakthroughs, and the Future of Pediatric Dermatologic Care.

Pediatric clinics of North America·2026
Same journal

Advancing Pediatric Dermatology: Innovations in Care and Access.

Pediatric clinics of North America·2026
Same journal

No Child Left Behind: Advancing Access in Pediatric Dermatology, a 4-Year, Single-Center Experience.

Pediatric clinics of North America·2026
Same journal

Telemedicine and Access to Pediatric Dermatology Care.

Pediatric clinics of North America·2026
Same journal

Inequitable Reimbursement for Pediatric Providers: A Review of Structural Factors that Disincentivize the Care of Children.

Pediatric clinics of North America·2026
Same journal

Medical Photography's Power to Change Medical Care.

Pediatric clinics of North America·2026
See all related articles

Related Experiment Video

Updated: Feb 10, 2026

Tail Vein Transection Bleeding Model in Fully Anesthetized Hemophilia A Mice
08:13

Tail Vein Transection Bleeding Model in Fully Anesthetized Hemophilia A Mice

Published on: September 30, 2021

7.6K

Evolving Complexity in Hemophilia Management.

Stacy E Croteau1

  • 1Boston Children's Hospital, 300 Longwood Avenue, Boston, MA 02115, USA.

Pediatric Clinics of North America
|May 28, 2018
PubMed
Summary
This summary is machine-generated.

Hemophilia care is evolving with new therapies improving quality of life. Aggressive prophylaxis and accurate diagnosis are key for active lifestyles in hemophilia patients.

Keywords:
Bispecific antibodyBleedingFactor IXFactor VIIIFactor concentrateGene therapyHemarthrosisInhibitors

More Related Videos

Designing Automated, High-throughput, Continuous Cell Growth Experiments Using eVOLVER
07:26

Designing Automated, High-throughput, Continuous Cell Growth Experiments Using eVOLVER

Published on: May 19, 2019

12.8K
Quantitative Analysis by Thermogravimetry-Mass Spectrum Analysis for Reactions with Evolved Gases
06:51

Quantitative Analysis by Thermogravimetry-Mass Spectrum Analysis for Reactions with Evolved Gases

Published on: October 29, 2018

10.1K

Related Experiment Videos

Last Updated: Feb 10, 2026

Tail Vein Transection Bleeding Model in Fully Anesthetized Hemophilia A Mice
08:13

Tail Vein Transection Bleeding Model in Fully Anesthetized Hemophilia A Mice

Published on: September 30, 2021

7.6K
Designing Automated, High-throughput, Continuous Cell Growth Experiments Using eVOLVER
07:26

Designing Automated, High-throughput, Continuous Cell Growth Experiments Using eVOLVER

Published on: May 19, 2019

12.8K
Quantitative Analysis by Thermogravimetry-Mass Spectrum Analysis for Reactions with Evolved Gases
06:51

Quantitative Analysis by Thermogravimetry-Mass Spectrum Analysis for Reactions with Evolved Gases

Published on: October 29, 2018

10.1K

Area of Science:

  • Hematology
  • Bleeding Disorders
  • Therapeutic Innovation

Background:

  • Hemophilia care has shifted from on-demand treatment to proactive prophylaxis, especially in pediatric patients.
  • This transition aims to reduce morbidity and mortality, enabling more active lifestyles for individuals with hemophilia.
  • Managing hemophilia now requires precise diagnosis and early identification of musculoskeletal complications.

Purpose of the Study:

  • To review the evolving landscape of hemophilia therapeutics.
  • To highlight the importance of comprehensive care strategies for hemophilia patients.
  • To discuss emerging treatments addressing unmet needs in bleeding disorders.

Main Methods:

  • Literature review of recent advancements in hemophilia treatment.
  • Analysis of the impact of prophylactic therapy on patient outcomes.
  • Exploration of novel therapeutic modalities including gene therapy and non-factor agents.

Main Results:

  • New therapeutic options offer improved management and quality of life for hemophilia patients.
  • Prophylaxis is increasingly recognized as essential for preventing joint damage and promoting activity.
  • Emerging therapies show promise in addressing specific challenges in hemophilia care.

Conclusions:

  • The expanding array of hemophilia treatments presents opportunities for personalized and effective care.
  • Optimizing diagnosis and therapy is crucial for both males and females with hemophilia.
  • Future directions include gene therapy and non-factor approaches to further improve hemophilia management.